Search by Drug Name or NDC

NDC 23155-0216-31 CIDOFOVIR DIHYDRATE 375 mg/5mL Details

CIDOFOVIR DIHYDRATE 375 mg/5mL

CIDOFOVIR DIHYDRATE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is CIDOFOVIR.

MedlinePlus Drug Summary

Cidofovir injection is used along with another medication (probenecid) to treat cytomegaloviral retinitis (CMV retinitis) in people with acquired immunodeficiency syndrome (AIDS). Cidofovir is in a class of medications called antivirals. It works by slowing the growth of CMV.

Related Packages: 23155-0216-31
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cidofovir Injection

Product Information

NDC	23155-0216
Product ID	23155-216_963405a6-8cd9-4d70-9de9-2afc6eab1488
Associated GPIs	12200010002020
GCN Sequence Number	027204
GCN Sequence Number Description	cidofovir VIAL 75 MG/ML INTRAVEN
HIC3	W5A
HIC3 Description	ANTIVIRALS, GENERAL
GCN	23190
HICL Sequence Number	011506
HICL Sequence Number Description	CIDOFOVIR
Brand/Generic	Generic
Proprietary Name	CIDOFOVIR DIHYDRATE
Proprietary Name Suffix	n/a
Non-Proprietary Name	CIDOFOVIR DIHYDRATE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	375
Active Ingredient Units	mg/5mL
Substance Name	CIDOFOVIR
Labeler Name	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Pharmaceutical Class	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog [EXT]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA202501
Listing Certified Through	2024-12-31

Package

NDC 23155-0216-31 (23155021631)

Pricing Information	N/A
NDC Package Code	23155-216-31
Billing NDC	23155021631
Package	5 mL in 1 VIAL, GLASS (23155-216-31)
Marketing Start Date	2012-08-06
NDC Exclude Flag	N